Table 5.
Myalgia | Sig. | Headache | Sig. | Malaise | Sig. | Fatigue | Sig. | |||
---|---|---|---|---|---|---|---|---|---|---|
AOR [95% CI] | p-Value | AOR [95% CI] | p-Value | AOR [95% CI] | p-Value | AOR [95% CI] | p-Value | |||
First Dose | Age: | ≤40 Yrs (vs. >40 Yrs) |
2.51 [1.41–4.47] | 0.002 | 1.63 [1.12–2.35] | 0.010 | 1.11 [0.70–1.77] | 0.663 | 1.85 [1.25–2.73] | 0.002 |
Gender: | Female (vs. Male) |
1.22 [0.79–1.91] | 0.373 | 1.74 [1.24–2.42] | 0.001 | 0.96 [0.63–1.46] | 0.842 | 1.51 [1.07–2.13] | 0.018 | |
Second Dose | Age: | ≤40 Yrs (vs. >40 Yrs) |
1.45 [0.53–3.95] | 0.472 | 1.13 [0.71–1.79] | 0.608 | 1.14 [0.47–2.74] | 0.772 | 2.06 [1.29–3.28] | 0.002 |
Gender: | Female (vs. Male) |
1.04 [0.44–2.44] | 0.927 | 1.69 [1.09–2.62] | 0.019 | 1.35 [0.60–3.06] | 0.467 | 2.16 [1.43–3.26] | <0.0001 |